In 2013, a novel avian influenza H7N9 virus was identified in human in China. The antigenically distinct H7N9 surface glycoproteins raised concerns about lack of cross-protective neutralizing antibodies. Epitope-specific preexisting T-cell immunity was one of the protective mechanisms in pandemic 2009 H1N1 even in the absence of cross-protective antibodies. Hence, the assessment of preexisting CD4+ T-cell immunity to conserved epitopes shared between H7N9 and human influenza A viruses (IAV) is critical. A comparative whole proteome-wide immunoinformatics analysis was performed to predict the CD4+ T-cell epitopes that are commonly conserved within the proteome of H7N9 in reference to IAV subtypes (H1N1, H2N2, and H3N2). The CD4+ T-cell epito...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but th...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
<div><p>In 2013, a novel avian influenza H7N9 virus was identified in human in China. The antigenica...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
Abstract Background The 2009 pandemic influenza was m...
Abstract Background The 2009 pandemic influenza was m...
ABSTRACT Against a backdrop of seasonal influenza virus epidemics, emerging avian influenza viruses ...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
Highly pathogenic avian influenza A (HPAI) H5N1 viruses have circulated continuously, posing a great...
Highly pathogenic avian influenza A (HPAI) H5N1 viruses have circulated continuously, posing a great...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but th...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
<div><p>In 2013, a novel avian influenza H7N9 virus was identified in human in China. The antigenica...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
The absence of preexisting neutralizing antibodies specific for the novel A (H7N9) influenza virus i...
Abstract Background The 2009 pandemic influenza was m...
Abstract Background The 2009 pandemic influenza was m...
ABSTRACT Against a backdrop of seasonal influenza virus epidemics, emerging avian influenza viruses ...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
Highly pathogenic avian influenza A (HPAI) H5N1 viruses have circulated continuously, posing a great...
Highly pathogenic avian influenza A (HPAI) H5N1 viruses have circulated continuously, posing a great...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...
Protective immunity against influenza virus infection is mediated by neutralizing antibodies, but th...
The threat of avian influenza A (H5N1) infection in humans remains a global health concern. Current ...